evidence based pcos
TRANSCRIPT
![Page 1: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/1.jpg)
Evidence Based PCOsEvidence Based PCOs
![Page 2: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/2.jpg)
IntroductionIntroduction
Polycystic ovarian syndrome (PCOS) Polycystic ovarian syndrome (PCOS) affects 4% to 12% of women of affects 4% to 12% of women of reproductive age. reproductive age.
hallmarks of the disease are hallmarks of the disease are hyperandrogenism and chronic hyperandrogenism and chronic anovulation anovulation
![Page 3: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/3.jpg)
Changing ApproachChanging Approach
management not only toward management not only toward treating infertility and improving the treating infertility and improving the often troublesome hirsutism but also often troublesome hirsutism but also toward the toward the long-term riskslong-term risks associated with IR. associated with IR.
![Page 4: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/4.jpg)
MoreoverMoreover
Recent data suggest that women Recent data suggest that women with PCOS are at increased risk for with PCOS are at increased risk for preterm labor, preeclampsia, and preterm labor, preeclampsia, and gestational diabetes, though the gestational diabetes, though the evidence for increased miscarriage evidence for increased miscarriage rates is less certain (Legro , 2007)rates is less certain (Legro , 2007)
![Page 5: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/5.jpg)
Ideal design to get best Ideal design to get best EvidenceEvidence
A randomised controlled trial (RCT) A randomised controlled trial (RCT) with large numbers and, ideally, with large numbers and, ideally, three groups is needed:three groups is needed:
women with PCOS taking medication,women with PCOS taking medication, women with PCOS taking no women with PCOS taking no
treatmenttreatment non-PCOS womennon-PCOS women
![Page 6: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/6.jpg)
metformin vs. both clomiphene metformin vs. both clomiphene and combination therapyand combination therapy
Metformin is not an effective Metformin is not an effective
additionaddition to clomifene citrate as to clomifene citrate as the primary method of inducing the primary method of inducing ovulation in women with polycystic ovulation in women with polycystic ovary syndrome ovary syndrome
![Page 7: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/7.jpg)
NEJM, 2007NEJM, 2007
The live-birth rate was The live-birth rate was 22.5%22.5% (47 of (47 of 209 subjects) in the clomiphene 209 subjects) in the clomiphene group, 7.2% (15 of 208) in the group, 7.2% (15 of 208) in the metformin group, and metformin group, and 26.8%26.8% (56 of (56 of 209) in the combination-therapy group 209) in the combination-therapy group
(P<0.001 for metformin vs. both (P<0.001 for metformin vs. both clomiphene and combination therapy; clomiphene and combination therapy; P=0.31 for clomiphene vs. P=0.31 for clomiphene vs. combination therapy). combination therapy).
![Page 8: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/8.jpg)
BMJ, 2007BMJ, 2007
Clomid alone vs clomid + metforminClomid alone vs clomid + metformin no significant differences in either no significant differences in either
rate of ongoing pregnancy (40% v rate of ongoing pregnancy (40% v 46%) 46%)
![Page 9: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/9.jpg)
HoweverHowever
gastrointestinal side effects were gastrointestinal side effects were more frequent with metformin armmore frequent with metformin arm
![Page 10: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/10.jpg)
AccordinglyAccordingly
Addition of metformin to clomid is Addition of metformin to clomid is not recommendednot recommended
![Page 11: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/11.jpg)
RecommendationsRecommendations
based on good and consistent based on good and consistent scientific evidence (Level A)scientific evidence (Level A)
![Page 12: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/12.jpg)
All women with polycystic ovary All women with polycystic ovary syndrome (PCOS) should be screened syndrome (PCOS) should be screened for glucose intolerance with a 2-hour for glucose intolerance with a 2-hour glucose level after a 75-g fasting glucose level after a 75-g fasting glucose challenge glucose challenge
![Page 13: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/13.jpg)
All women with PCOS should be All women with PCOS should be screened for dyslipidemia with a screened for dyslipidemia with a fasting lipoprotein profile, including fasting lipoprotein profile, including total cholesterol, low-density total cholesterol, low-density lipoprotein (LDL) cholesterol, high-lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, density lipoprotein (HDL) cholesterol, and triglyceride determinations. and triglyceride determinations.
![Page 14: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/14.jpg)
LIFESTYLE MODIFICATION LIFESTYLE MODIFICATION WEIGHT LOSSWEIGHT LOSS
A 3 to 6 month trial of aggressive A 3 to 6 month trial of aggressive lifestyle modification may be a lifestyle modification may be a prudent first step before considering prudent first step before considering medications. medications.
However, many patients will have However, many patients will have difficulty in achieving weight loss difficulty in achieving weight loss
![Page 15: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/15.jpg)
Use of clomiphene citrate is Use of clomiphene citrate is appropriate because it effectively appropriate because it effectively results in pregnancy in women with results in pregnancy in women with PCOS. (Hughes, 1997) PCOS. (Hughes, 1997)
![Page 16: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/16.jpg)
The following recommendations The following recommendations are based on limited or are based on limited or inconsistent scientific evidence inconsistent scientific evidence (Level B)(Level B)
![Page 17: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/17.jpg)
Long termLong term
Improvements in insulin sensitivity, Improvements in insulin sensitivity, by weight loss may favorably by weight loss may favorably improve many risk factors for improve many risk factors for diabetes and cardiovascular disease diabetes and cardiovascular disease in women with PCOS. in women with PCOS.
![Page 18: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/18.jpg)
When using gonadotropins to induce When using gonadotropins to induce ovulation, low-dose therapy is ovulation, low-dose therapy is recommended because it offers a recommended because it offers a high rate of monofollicular high rate of monofollicular development and a significantly development and a significantly lower risk of ovarian lower risk of ovarian hyperstimulation in women with hyperstimulation in women with PCOS. PCOS.
![Page 19: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/19.jpg)
Ovarian drillingOvarian drilling
The clear benefit and role of surgical The clear benefit and role of surgical therapy in ovulation induction in therapy in ovulation induction in women with PCOS is uncertain. women with PCOS is uncertain.
![Page 20: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/20.jpg)
The following recommendations The following recommendations are based primarily on are based primarily on consensus and expert opinion consensus and expert opinion (Level C)(Level C)
![Page 21: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/21.jpg)
HirsutismHirsutism
Combining medical interventions Combining medical interventions may be the most effective way to may be the most effective way to treat hirsutism. Combined therapy treat hirsutism. Combined therapy with an ovarian suppression agent with an ovarian suppression agent and an antiandrogen appears and an antiandrogen appears effective in treating hirsutism in effective in treating hirsutism in women with PCOS. The best pill or women with PCOS. The best pill or antiandrogen is unknown. antiandrogen is unknown.
![Page 22: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/22.jpg)
Ablation techniquesAblation techniques
The ideal choice of ablative The ideal choice of ablative procedures for long-term procedures for long-term management of hirsutism in women management of hirsutism in women with PCOS is unknown. with PCOS is unknown.
![Page 23: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/23.jpg)
During PregnancyDuring Pregnancy
The effects of insulin-sensitizing The effects of insulin-sensitizing agents on early pregnancy are agents on early pregnancy are unknown; metformin appears safe, unknown; metformin appears safe, but any additional effect at reducing but any additional effect at reducing pregnancy loss is uncertain pregnancy loss is uncertain
![Page 24: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/24.jpg)
Side Effects of Side Effects of MedicationMedication
ProgestinsProgestins. Use of . Use of medroxyprogesterone acetate is medroxyprogesterone acetate is associated with decreases in sex associated with decreases in sex hormone binding globulin (SHBG). hormone binding globulin (SHBG). Progestin-only oral contraceptives Progestin-only oral contraceptives are associated with high incidence of are associated with high incidence of breakthrough bleeding. breakthrough bleeding.
![Page 25: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/25.jpg)
GnGn
Use of gonadotrophins can result in Use of gonadotrophins can result in ovarian hyperstimulation syndrome ovarian hyperstimulation syndrome
![Page 26: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/26.jpg)
Insulin-sensitizing agentsInsulin-sensitizing agents
The most common adverse reactions The most common adverse reactions of metformin are gastrointestinal of metformin are gastrointestinal symptoms (diarrhea, nausea, symptoms (diarrhea, nausea, vomiting, abdominal bloating, vomiting, abdominal bloating, flatulence, and anorexia). flatulence, and anorexia).
![Page 27: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/27.jpg)
Troglitazone had been associated Troglitazone had been associated with an increased risk of with an increased risk of hepatotoxicity and was removed hepatotoxicity and was removed from the market. from the market.
![Page 28: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/28.jpg)
Cosmetic management of Cosmetic management of hirsutismhirsutism
Plucking can cause folliculitis, Plucking can cause folliculitis, pigmentation, and scarring. pigmentation, and scarring.
Electrolysis is tedious, its success is Electrolysis is tedious, its success is highly operator-dependent, and it highly operator-dependent, and it may be impractical for treating large may be impractical for treating large numbers of hairs. numbers of hairs.
Laser treatment is also operator-Laser treatment is also operator-dependent and multiple treatments dependent and multiple treatments may be necessary may be necessary
![Page 29: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/29.jpg)
FutureFuture
There are few data to support There are few data to support treatment during pregnancy with treatment during pregnancy with metformin in women with PCOS to metformin in women with PCOS to prevent pregnancy loss or pregnancy prevent pregnancy loss or pregnancy complications.complications.(Legro, 2007)(Legro, 2007)
![Page 30: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/30.jpg)
it may be time to take it may be time to take PCOS in pregnancy PCOS in pregnancy
seriouslyseriously
![Page 31: Evidence based PCOs](https://reader036.vdocuments.mx/reader036/viewer/2022062319/554b10ccb4c9055d098b4934/html5/thumbnails/31.jpg)
Thank YouThank You